MEDIGUS LTD's ticker is MDGSW and the CUSIP is 58471G128. A total of 4 filers reported holding MEDIGUS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,347 | +43.4% | 55,486 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $1,637 | -72.7% | 55,486 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -57.1% | 55,486 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $14,000 | -6.7% | 55,486 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | +25.0% | 55,486 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $12,000 | -45.5% | 55,486 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $22,000 | -26.7% | 55,486 | -4.3% | 0.00% | -50.0% |
| Q2 2021 | $30,000 | -40.0% | 57,986 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $50,000 | +127.3% | 57,986 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $22,000 | +120.0% | 57,986 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | -16.7% | 57,986 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +1100.0% | 57,986 | -8.4% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | -83.3% | 63,286 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $6,000 | 0.0% | 63,286 | 0.0% | 0.01% | -38.5% |
| Q3 2019 | $6,000 | -85.7% | 63,286 | -67.2% | 0.01% | -18.8% |
| Q2 2019 | $42,000 | +44.8% | 192,858 | +200.0% | 0.02% | -40.7% |
| Q1 2019 | $29,000 | -9.4% | 64,286 | 0.0% | 0.03% | -62.0% |
| Q4 2018 | $32,000 | -31.9% | 64,286 | 0.0% | 0.07% | -9.0% |
| Q3 2018 | $47,000 | – | 64,286 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 55,486 | $2,347 | 0.00% |
| Skaana Management L.P. | 67,920 | $2,309 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 11,946 | $505 | 0.00% |
| ARMISTICE CAPITAL, LLC | 85,714 | $5,057 | 0.00% |
| JPMORGAN CHASE & CO | 478 | $28 | 0.00% |
| UBS Group AG | 2,855 | $97 | 0.00% |